# ClinicalTrials.gov record NCT07732426

> PeptideScanner retained ClinicalTrials.gov record NCT07732426 at 2026-08-10T18:10:03.951Z. Its registry update date was 2026-07-28, and PeptideScanner's reviewed identity mapping was semaglutide.

- Evidence object: `story:clinicaltrials-gov-nct07732426-semaglutide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-07-28
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07732426-semaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct07732426-semaglutide-v1.json
- Content SHA-256: `507038cffaca087d6217da38298a40657e68fb4dc4883d2b9706c356894de048`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT07732426 ([`ctg-observation-nct07732426-2026-07-28-8b2f88005f52`](#source-ctg-observation-nct07732426-2026-07-28-8b2f88005f52))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07732426 at 2026-08-10T18:10:03.951Z. Its registry update date was 2026-07-28, and PeptideScanner's reviewed identity mapping was semaglutide. ([`ctg-observation-nct07732426-2026-07-28-8b2f88005f52`](#source-ctg-observation-nct07732426-2026-07-28-8b2f88005f52))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07732426 at 2026-08-10T18:10:03.951Z. Its registry update date was 2026-07-28, and PeptideScanner's reviewed identity mapping was semaglutide. ([`ctg-observation-nct07732426-2026-07-28-8b2f88005f52`](#source-ctg-observation-nct07732426-2026-07-28-8b2f88005f52))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07732426-2026-07-28-8b2f88005f52`](#source-ctg-observation-nct07732426-2026-07-28-8b2f88005f52))

## Sources

<a id="source-ctg-observation-nct07732426-2026-07-28-8b2f88005f52"></a>
- **ClinicalTrials.gov record NCT07732426 · retained source version 2026-07-28:8b2f88005f52ca03d9b5eee89c48a95e11bbc50c4561d98cac6e5483c25742b0** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07732426) (`ctg-observation-nct07732426-2026-07-28-8b2f88005f52`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07732426." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct07732426-semaglutide-v1.json SHA-256: 507038cffaca087d6217da38298a40657e68fb4dc4883d2b9706c356894de048.